Robert E. Campbell

Director/Board Member at

The Cancer Institute of New Jersey

92 year

91 connections

Health Technology

Miscellaneous

Consumer Services

Profile

Dr. Robert E.
Campbell is Chairman at The Cancer Institute of New Jersey and an Advisory Board Member at Plebys International LLC.
He has been a Director of Barrier Therapeutics, Inc. since September 2004.
He is also on the Advisory Board of Plebys International.
Previously, he was Vice Chairman of Johnson & Johnson from April 1989 to January 1995.
He held various positions with Johnson & Johnson, including Vice Chairman of the Executive Committee, Chairman of the Professional Sector and Chief Financial Officer.
He is Chairman of the Board of Advisors for The Cancer Institute of New Jersey and a past Chairman and present Board Member of The Robert Wood Johnson Foundation and Fordham University.
Dr. Campbell received a BS from Fordham University and an MBA from Rutgers University.

Robert E. Campbell active positions

Companies	Position	Start
The Cancer Institute of New Jersey The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center	Director/Board Member	-
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Director/Board Member	-
Rutgers University Foundation Rutgers University Foundation Investment Trusts/Mutual FundsMiscellaneous Provides fund raising services	Director/Board Member	-

All active positions of Robert E. Campbell

Former positions of Robert E. Campbell

Companies	Position	End
The Robert Wood Johnson Foundation The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous RWJF seeks to earn an investment return that, over time, equals or exceeds the sum of its annual spending, as a percentage of the Foundation’s assets plus the rate of inflation. This balance of investment return and spending is designed to spread risk and promote a steady, stable flow of support for our grantees. Since the firm focuses their philanthropy on meeting many of the nation’s most critical health challenges, they seek to avoid investments in companies whose businesses are predominantly related to the manufacture, sale, or distribution of firearms, alcohol, cannabis, or tobacco-related products.	Corporate Officer/Principal	2008-12-30
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products in the field of dermatology	Director/Board Member	2008-08-03
JOHNSON & JOHNSON	Director of Finance/CFO	1994-12-31
US Department of Defense (District of Columbia) US Department of Defense (District of Columbia) SovereignGovernment Operates and maintains defense departments	Corporate Officer/Principal	1958-12-30
Mesoblast, Inc. Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products	Director/Board Member	-

See the detail of Robert E. Campbell's experience

Training of Robert E. Campbell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert E. Campbell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
The Robert Wood Johnson Foundation The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous RWJF seeks to earn an investment return that, over time, equals or exceeds the sum of its annual spending, as a percentage of the Foundation’s assets plus the rate of inflation. This balance of investment return and spending is designed to spread risk and promote a steady, stable flow of support for our grantees. Since the firm focuses their philanthropy on meeting many of the nation’s most critical health challenges, they seek to avoid investments in companies whose businesses are predominantly related to the manufacture, sale, or distribution of firearms, alcohol, cannabis, or tobacco-related products.	Miscellaneous
Barrier Therapeutics, Inc. Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products in the field of dermatology	Health Technology
Mesoblast, Inc. Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products	Health Technology
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fordham University Fordham University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
US Department of Defense (District of Columbia) US Department of Defense (District of Columbia) SovereignGovernment Operates and maintains defense departments	Government
The Cancer Institute of New Jersey The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services Operates cancer center	Health Services
Rutgers University Foundation Rutgers University Foundation Investment Trusts/Mutual FundsMiscellaneous Provides fund raising services	Miscellaneous